Your browser doesn't support javascript.
loading
Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer.
Marastoni, Stefano; Madariaga, Ainhoa; Pesic, Aleksandra; Nair, Sree Narayanan; Li, Zhu Juan; Shalev, Zvi; Ketela, Troy; Colombo, Ilaria; Mandilaras, Victoria; Cabanero, Michael; Bruce, Jeff P; Li, Xuan; Garg, Swati; Wang, Lisa; Chen, Eric X; Gill, Sarbjot; Dhani, Neesha C; Zhang, Wenjiang; Pintilie, Melania; Bowering, Valerie; Koritzinsky, Marianne; Rottapel, Robert; Wouters, Bradly G; Oza, Amit M; Joshua, Anthony M; Lheureux, Stephanie.
Afiliación
  • Marastoni S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Madariaga A; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Pesic A; Autonomous University of Barcelona, Barcelona, Spain.
  • Nair SN; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Li ZJ; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Shalev Z; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Ketela T; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Colombo I; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Mandilaras V; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Cabanero M; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Bruce JP; Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada.
  • Li X; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Garg S; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Wang L; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Chen EX; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Gill S; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Dhani NC; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Zhang W; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Pintilie M; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Bowering V; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Koritzinsky M; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Rottapel R; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Wouters BG; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Oza AM; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Joshua AM; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Lheureux S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Cancer Res Commun ; 2(5): 293-306, 2022 05.
Article en En | MEDLINE | ID: mdl-36875717
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Cancer Res Commun Año: 2022 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Cancer Res Commun Año: 2022 Tipo del documento: Article País de afiliación: Canadá